GoodRx Holdings, Inc. Class A Common Stock
Here’s whether GoodRx Holdings, Inc. Class A Common Stock (GDRX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.27% over 10 days); 3-month momentum positive (+53.5%); rising volume confirms the move (1.56x 30d avg). Concerns: RSI 70 — overbought, elevated pullback risk. Currently 35.8% off its 52-week high. Score: +5/7.
GDRX is in a confirmed uptrend, trading above both its 50-day ($3.02) and 200-day ($2.67) moving averages. With an RSI of 70.5, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +5.4% compares to +20.4% for SPY (trailed the market by 15.0%). The current 35.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.